Vol. 139, No. 22 — May 28, 2005

CANADA CUSTOMS AND REVENUE AGENCY

INCOME TAX ACT

Revocation of registration of a charity

The following notice of proposed revocation was sent to the charity listed below revoking it for failure to meet the parts of the Income Tax Act as listed in this notice:

"Notice is hereby given, pursuant to paragraph 168(1)(b) of the Income Tax Act, that I propose to revoke the registration of the charity listed below and that by virtue of paragraph 168(2)(b) thereof, the revocation of the registration is effective on the date of publication of this notice in the Canada Gazette."

ELIZABETH TROMP
Director General
Charities Directorate

[22-1-o]

HEALTH OF ANIMALS ACT

Consultation on an import policy on bovine spongiform encephalopathy (BSE)

Intent

This notice announces the publication of a consultation paper inviting public comment on a proposed new Canadian import policy to prevent bovine spongiform encephalopathy (BSE) in bovine animals and their products.

Description

The proposed policy would bring Canada's approach in line with new World Organization for Animal Health (OIE) standards as well as the proposed North American import standard announced on March 29, 2005. It is based on the recognition that international knowledge of BSE and measures to mitigate its transmission have advanced significantly since Canada's existing import policy for controlling BSE was established in 1997.

An international team of BSE experts reviewed the Canadian situation and recommended that Canadian policy be brought into line with the OIE standards, noting that this would demonstrate leadership in encouraging a more rational regulatory response to BSE detection by governments around the world. The new policy would also be consistent with the regulatory treatment that Canada is requesting of other countries with respect to exports from Canada.

The new policy would be less restrictive than the current one. Canada's current policy permits the importation of live ruminants, including cattle, sheep and goats and products derived from them only after the exporting country has been officially recognized by the Canadian Food Inspection Agency (CFIA) as BSE-free based on a risk assessment. Current science recognizes that the "BSE-free" requirement is unnecessarily restrictive.

The draft policy is based on a proposed new OIE three-tier system for classifying bovine-trading countries based on their BSE risk management regimes. In all cases, exporting countries would also have to continue to meet other non-BSE food safety and animal health requirements before becoming eligible to ship to Canada under any of the new BSE risk categories.

The commodity focus of the proposed policy would be narrowed from the existing policy; it would apply only to bovine animals (including cattle and bison) and their products. The existing policy would continue to apply to other ruminant species, such as sheep and goats, until import policies specific to these species are developed and implemented.

A consultation period ending on July 22, 2005, is being provided to allow interested parties the opportunity to provide comments on the draft policy.

Obtaining copies

Copies of the consultation paper are available electronically on the CFIA's Web site at www.inspection.gc.ca/english/anima/ heasan/disemala/bseesb/imp/consulpape.shtml.

Submitting comments

Comments are requested by July 22, 2005. They should be addressed to the Director of Animal Health and Production Division, Canadian Food Inspection Agency, 59 Camelot Drive, 2nd Floor, Room 237 W, Ottawa, Ontario K1A 0Y9. Electronic comments may be provided at www.inspection.gc.ca/english/ tools/feedback/commene.shtml?clarkj; and technical questions may be addressed to Dr. Noel Murray, Senior Advisor, Animal Health and Production Division, (613) 225-2342 (extension 4481) [telephone], (613) 228-6144 (facsimile), www.inspection.gc.ca/ english/tools/feedback/commene.shtml?murrayj.

May 28, 2005

DR. JIM CLARK
Director
Animal Health and Production Division

[22-1-o]

DETERMINATION

Transportation, travel and relocation services

Notice is hereby given that, after completing its inquiry, the Canadian International Trade Tribunal (the Tribunal) made a determination (File No. PR-2004-054) on May 16, 2005, with respect to a complaint filed by Envoy Relocation Services (Envoy), under subsection 30.11(1) of the Canadian International Trade Tribunal Act, R.S.C. 1985 (4th Supp.), c. 47, as amended by the North American Free Trade Agreement Implementation Act, S.C. 1993, c. 44, concerning a procurement (Solicitation No. 24062-030147/C) by the Department of Public Works and Government Services (PWGSC). The solicitation was for the provision of relocation assistance services to government employees and military personnel.

Envoy alleged that PWGSC failed to evaluate its proposals in accordance with the solicitation's published evaluation criteria.

Having examined the evidence presented by the parties and considered the provisions of the Agreement on Internal Trade, the Tribunal determined that the complaint was valid.

Further information may be obtained from the Secretary, Canadian International Trade Tribunal, Standard Life Centre, 15th Floor, 333 Laurier Avenue W, Ottawa, Ontario K1A 0G7, (613) 993-3595 (telephone), (613) 990-2439 (facsimile).

Ottawa, May 16, 2005

HÉLÈNE NADEAU
Secretary

[22-1-o]

NOTICE TO INTERESTED PARTIES

The following notices are abridged versions of the Commission's original notices bearing the same number. The original notices contain a more detailed outline of the applications, including additional locations and addresses where the complete files may be examined. The relevant material, including the notices and applications, is available for viewing during normal business hours at the following offices of the Commission:

— Central Building, Les Terrasses de la Chaudière, Room G-5, 1 Promenade du Portage, Gatineau, Quebec K1A 0N2, (819) 997-2429 (telephone), 994-0423 (TDD), (819) 994-0218 (facsimile);

— Metropolitan Place, Suite 1410, 99 Wyse Road, Dartmouth, Nova Scotia B3A 4S5, (902) 426-7997 (telephone), 426-6997 (TDD), (902) 426-2721 (facsimile);

— Kensington Building, Suite 1810, 275 Portage Avenue, Winnipeg, Manitoba R3B 2B3, (204) 983-6306 (telephone), 983-8274 (TDD), (204) 983-6317 (facsimile);

— 530-580 Hornby Street, Vancouver, British Columbia V6C 3B6, (604) 666-2111 (telephone), 666-0778 (TDD), (604) 666-8322 (facsimile);

— C.R.T.C. Documentation Centre, 205 Viger Avenue W, Suite 504, Montréal, Quebec H2Z 1G2, (514) 283-6607 (telephone), 283-8316 (TDD), (514) 283-3689 (facsimile);

— C.R.T.C. Documentation Centre, 55 St. Clair Avenue E, Suite 624, Toronto, Ontario M4T 1M2, (416) 952-9096 (telephone), (416) 954-6343 (facsimile);

— C.R.T.C. Documentation Centre, Cornwall Professional Building, Room 103, 2125 11th Avenue, Regina, Saskatchewan S4P 3X3, (306) 780-3422 (telephone), (306) 780-3319 (facsimile);

— C.R.T.C. Documentation Centre, 10405 Jasper Avenue, Suite 520, Edmonton, Alberta T5J 3N4, (780) 495-3224 (telephone), (780) 495-3214 (facsimile).

Interventions must be filed with the Secretary General, Canadian Radio-television and Telecommunications Commission, Ottawa, Ontario K1A 0N2, together with proof that a true copy of the intervention has been served upon the applicant, on or before the deadline given in the notice.

Secretary General

DECISIONS

The complete texts of the decisions summarized below are available from the offices of the CRTC.

2005-196 May 16, 2005

Kesitah Inc.
Winnipeg, Manitoba

Denied — Change of its condition of licence relating to expenditures on Canadian talent development.

2005-197 May 16, 2005

Jim Pattison Broadcast Group Ltd. (the general partner) and Jim Pattison Industries Ltd. (the limited partner), carrying on business as Jim Pattison Broadcast Group Limited Partnership
Chase, British Columbia

Approved — Acquisition of the assets of the radiocommunication distribution undertaking CHSH-TV-2 Chase from Shuswap Lakes Television Society and change of the programming source from CFJC-TV Kamloops to CHKM-TV Kamloops. The new licence will expire August 31, 2010.

2005-198 May 16, 2005

Rogers Cable Communications Inc.
Various locations in Ontario, Quebec, New Brunswick and Newfoundland and Labrador

Approved in part — Suspension of the requirement to perform non-simultaneous program deletion, set out in Carriage of Canadian and U.S. 4+1 signals on a digital discretionary basis, Decision CRTC 2000-437, November 8, 2000.

2005-199 May 18, 2005

Corus Entertainment Inc., on behalf of its subsidiaries
Across Canada

Approved — Addition of a condition of licence that will allow the licensees to avail themselves of the incentive program for English-language Canadian television drama, as noted in the decision.

2005-200 May 18, 2005

Aylmer and Area Inter-Mennonite Community Council
Aylmer, Ontario

Approved — Technical change for the low-power ethnic radio programming undertaking CHPD-FM Aylmer, as noted in the decision.

2005-201 May 18, 2005

Câblevision TRP-SDM inc.
Trois-Pistoles, Saint-Fabien, Rimouski, Mont-Joli, Matane, Rivière-du-Loup and surrounding areas, Quebec

Approved — Renewal of the broadcasting licence to distribute broadcasting services using multipoint distribution system (MDS) technology in Trois-Pistoles, Saint-Fabien, Rimouski, Mont-Joli, Matane and Rivière-du-Loup, from September 1, 2005, to August 31, 2009.

Approved — Authority to distribute, on an analog basis in each of the licensed areas, MétéoMédia, MusiquePlus, VRAK.TV, Séries +, Canal Z and Canal Vie as part of the basic service, and Super Écran on a discretionary basis.

2005-202 May 19, 2005

Rogers Broadcasting Limited
Ottawa, Ontario

Approved — New transmitter in Ottawa for the transitional digital television programming undertaking CJMT-DT Toronto.

2005-203 May 19, 2005

Rogers Broadcasting Limited
Ottawa, Ontario

Approved — New transmitter in Ottawa for the transitional digital television programming undertaking CFMT-DT Toronto.

2005-204 May 19, 2005

CHUM Limited
City of Kawartha Lakes (Lindsay), Ontario

Approved — Technical change of the radio programming undertaking CKLY-FM City of Kawartha Lakes (Lindsay), as noted in the decision.

2005-205 May 19, 2005

Pineridge Broadcasting Inc.
Cobourg, Ontario

Approved — New English-language FM radio programming undertaking at Cobourg to replace its AM station CHUC. The licence will expire August 31, 2011.

Denied — Authority to simulcast the programming of the new FM station on CHUC for a period of six months following the launch of the new station.

2005-206 May 19, 2005

CTV Television Inc., on behalf of a corporation to be incorporated
Across Canada

Approved — Corporate reorganization that will result in the transfer of the assets of the English-language specialty programming undertaking Talk TV, to a wholly-owned subsidiary of CTV Television. The licence will expire August 31, 2010.

[22-1-o]

PUBLIC NOTICE 2005-52

Call for comments — Proposed amendments to the Exemption order respecting closed circuit video programming undertakings

The Commission calls for comments on proposed amendments to the Exemption order respecting closed circuit video programming undertakings. The purpose of these undertakings is to provide a programming service to the temporary residents of hotels, motels and hospitals or to the inmates of prisons. In most cases, the programming service is provided in conjunction with the services distributed by a licensed, cable-based broadcasting distribution undertaking (BDU) or by an exempt master antenna television system (MATV) BDU. In those cases, the exemption order, as currently drafted, requires that a closed circuit video programming undertaking be operated in a manner that does not prevent those served by the undertaking from receiving certain specified programming services when those services are provided by the BDU.

The amendments would (a) broaden the application of this requirement so as to include circumstances where the service of the exempt programming undertaking is provided in conjunction with the services distributed by other types of BDUs, such as a licensed direct-to-home satellite BDU or an exempt BDU; and (b) expand the BDU-delivered services specified within the requirement to include those of the Aboriginal Peoples Television Network, the French-language television network TVA, the Cable Public Affairs Channel, and the programming of at least one licensed national English-language all-news television service and of at least one such service operating in French when these services are offered by the BDU as part of the basic service.

The deadline for the submission of written comments in the first stage is August 19, 2005. The Commission will accept comments that it receives on or before that date.

Interested parties, including those who may not have participated in the first written stage, will then have an opportunity to submit written comments in the second stage regarding any issue raised in the first round of comments. The deadline for written comments submitted as part of this second stage is October 19, 2005.

May 19, 2005

[22-1-o]

PUBLIC NOTICE2005-53

The Commission has received the following applications. The deadline for submission of interventions and/or comments is June 23, 2005.

1. Ten Broadcasting Inc.
Across Canada

To amend the licences of the national Category 2 specialty programming undertakings known as Hustler TV and X Channel.

May 19, 2005

[22-1-o]

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Haz-ardous Materials Information Review Commission hereby gives notice of the decisions of the Screening Officer, respecting each claim for exemption, the relevant Material Safety Data Sheet (MSDS) and the label (where applicable), listed below.

Notes: 1. The Notice of Filing published in the Canada Gazette, Part I, on December 9, 2000, listed the subject of the claim bearing Registry Number 4763 to be the chemical identity and concentration of six ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of seven ingredients.

2. The Notice of Filing published in the Canada Gazette, Part I, on May 5, 2001, listed the subject of the claim bearing Registry Number 4951 to be the chemical identity of three ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of five ingredients.

3. The Notice of Filing published in the Canada Gazette, Part I, on May 5, 2001, listed the subject of the claim bearing Registry Number 4976 to be the chemical identity of two ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of four ingredients.

4. The Notice of Filing published in the Canada Gazette, Part I, on May 5, 2001, listed the subject of the claim bearing Registry Number 4987 to be the chemical name, common name, generic name, trade name or brand name of a controlled product and information which could be used to identify the supplier of a controlled product of one ingredient. It also identified the claim as being filed by Schlumberger of Sugar Land, Texas, as seeking exemption from the disclosure of employer confidential information in respect of a controlled product which would otherwise be required to be disclosed by the provisions of the applicable provincial legislation relating to occupational health and safety.

It has since been established that the subject of the claim is the chemical identity of one ingredient and the claim is filed by Schlumberger Canada Limited of Calgary, Alberta, who is seeking exemption from the disclosure of supplier confidential business information in respect of a controlled product; such disclosure would otherwise be required under the provisions of the Hazardous Products Act. The Screening Officer issued the decision on that basis.

5. The Notice of Filing published in the Canada Gazette, Part I, on May 5, 2001, listed the subject of the claim bearing Registry Number 5022 to be the chemical identity of four ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of five ingredients.

6. The Notice of Filing published in the Canada Gazette, Part I, on August 18, 2001, listed the subject of the claim bearing Registry Number 5121 to be information which could be used to identify the supplier of a controlled product of one ingredient. The subject of the claim on which the Screening Officer issued the decision is information which could be used to identify the supplier of a controlled product and the chemical identity of one ingredient.

7. The Notice of Filing published in the Canada Gazette, Part I, on January 19, 2002, listed the subject of the claim bearing Registry Number 5284 to be the chemical identity and concentration of one ingredient. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of one ingredient.

8. The Notice of Filing published in the Canada Gazette, Part I, on July 20, 2002, listed the subject of the claim bearing Registry Number 5366 to be the chemical identity of two ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of one ingredient.

9. The Notice of Filing published in the Canada Gazette, Part I, on July 20, 2002, listed the subject of the claim bearing Registry Number 5371 to be the chemical identity of four ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of nine ingredients.

10. The Notice of Filing published in the Canada Gazette, Part I, on July 20, 2002, listed the subjects of the claims bearing Registry Numbers 5422 and 5424 to be the chemical identities of one and two ingredients, respectively. The subjects of the claims on which the Screening Officer issued the decisions are the chemical identities of two and one ingredient, respectively.

11. The Notice of Filing published in the Canada Gazette, Part I, on December 14, 2002, listed the subject of the claim bearing Registry Number 5471 to be the "chemical name, common name, generic name, trade name or brand name of a controlled product of one ingredient". The subject of the claim on which the Screening Officer issued the decision is information which could be used to identify the supplier of a controlled product and the chemical identity of one ingredient.

12. The Notice of Filing published in the Canada Gazette, Part I, on December 14, 2002, listed the subject of the claim bearing Registry Number 5532 to be the chemical identity of four ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of nine ingredients.

13. The Notice of Filing published in the Canada Gazette, Part I, on July 26, 2003, listed the subject of the claim bearing Registry Number 5552 to be the chemical identity of two ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of four ingredients.

14. The Notice of Filing published in the Canada Gazette, Part I, on July 17, 2004, listed the subject of the claim bearing Registry Number 5931 to be the chemical identity and concentration of two ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of three ingredients.

15. The Notice of Filing published in the Canada Gazette, Part I, on July 17, 2004, listed the subject of the claim bearing Registry Number 5941 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of three ingredients and the concentration of two ingredients.

16. The Notice of Filing published in the Canada Gazette, Part I, on July 17, 2004, listed the subject of the claim bearing Registry Number 5973 to be the chemical identity of seven ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of seven ingredients.

There were no submissions from affected parties to the Screening Officer with respect to any of the above claims for exemption and related MSDSs.

Each of the claims for exemption listed above was found to be valid. The Screening Officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations. Having regard for the various data readily available in the literature and any information provided by the claimant, the Screening Officer found that the respective MSDS relating to the claims bearing Registry Numbers 4902, 5284, 5770, 5941 and 5973 complied with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

In the case of the claims bearing Registry Numbers 5121 and 5471, being claims from an employer in the province of Alberta, the Screening Officer found that the MSDSs and the labels relating to these claims did not comply with the applicable disclosure requirements of the Occupational Health and Safety Code of the Province of Alberta.

Having regard for the various data readily available in the literature and any information provided by the claimant, the Screening Officer found that the respective MSDS relating to the remaining claims did not comply with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

Registry Number 4763

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product;

2. Disclose Exposure Limit Values for four of the confidential hazardous ingredients;

3. Disclose a lower Exposure Limit Value ACGIH TLV– TWA = 0.01 ppm with a skin notation for one of the confidential hazardous ingredients;

4. Disclose that chronic inhalation of the vapours of an ingredient in the controlled product has caused adverse lung and kidney effects in an occupationally exposed worker and that acute inhalation has been shown to cause CNS effects in laboratory animals;

5. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause ulceration of the gastric mucosa, atrophy of the heart muscle and adverse sperm effects in laboratory animals;

6. Disclose that an ingredient in the controlled product is a fetotoxin and a teratogen;

7. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for 20 minutes or until the chemical is removed. Also disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

8. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with water for 20 minutes or until the chemical is removed. Also disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

9. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

10. Add metals and metal oxides to the list of incompatible materials;

11. Disclose lower LD₅₀ values for two of the confidential hazardous ingredients;

12. Disclose dermal LD₅₀ values for two of the confidential hazardous ingredients in an acceptable manner;

13. Disclose lower LC₅₀ values for two of the confidential hazardous ingredients;

14. Disclose LC₅₀ values for two of the confidential hazardous ingredients in an acceptable manner;

15. Disclose that an ingredient in the controlled product has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC);

16. Disclose that ingredients in the controlled product have been shown to cause fetotoxicity and teratogenicity in laboratory animals and have been shown to cause behavioural abnormalities in offspring of laboratory animals;

17. Disclose that an ingredient in the controlled product has shown positive test results in in vivo screening tests for mutagenicity, and disclose that another ingredient in the controlled product has shown positive test results in in vitro screening tests for mutagenicity;

18. Disclose that an ingredient in the controlled product has caused synergistic and potentiating effects with a wide range of industrial chemicals;

19. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1A, D2A and D2B.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 4808

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose LD₅₀ values for three of the confidential hazardous ingredients in an acceptable manner;

2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement such as the following: Never give anything by mouth if the casualty is rapidly losing consciousness, or is unconscious or convulsing;

3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 20–30 minutes;

4. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion in laboratory animals;

5. Disclose that an ingredient in the controlled product has shown positive test results in an in vivo screening test for mutagenicity, and disclose that another ingredient in the controlled product has shown positive test results in in vitro screening tests for mutagenicity;

6. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals.

Registry Number 4809

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentrations of propylene glycol monomethyl ether, n-propoxy propanol and n-propanol in an acceptable manner;

2. Disclose LD₅₀ values for two of the confidential hazardous ingredients in an acceptable manner;

3. Disclose an LD₅₀ (oral, rat) value of 3 739 mg/kg for propylene glycol monomethyl ether;

4. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse effects on male reproductive potency in laboratory animals.

Registry Numbers 4810 and 4812

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose LD₅₀ values for one of the confidential hazardous ingredients in an acceptable manner;

2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement such as the following: Never give anything by mouth if the casualty is rapidly losing consciousness, or is unconscious or convulsing;

3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 20–30 minutes;

4. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion in laboratory animals;

5. Disclose that an ingredient in the controlled product has shown positive test results in an in vivo screening test for mutagenicity, and disclose that another ingredient in the controlled product has shown positive test results in in vitro screening tests for mutagenicity;

6. Registry Number 4812: Disclose LD₅₀ values for another of the confidential hazardous ingredients in an acceptable manner.

Registry Number 4951

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of two additional confidential hazardous ingredients in the controlled product, together with their percent concentrations;

2. In relation to the first aid information shown on the MSDS for ingestion, delete the statement to give plenty of water to drink;

3. Add oxides of sulphur to the list of hazardous decomposition products;

4. Add skin contact and eye contact as routes of entry;

5. Disclose that ingredients in the controlled product have been shown to cause skin irritation in laboratory animals;

6. Disclose that ingredients in the controlled product have been shown to cause eye irritation in laboratory animals.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 4976

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statements to give water to drink;

3. Add oxides of sulphur to the list of hazardous combustion products;

4. Add skin contact and eye contact as routes of entry;

5. Disclose that an ingredient in the controlled product has shown positive results in an in vitro screening test for mutagenicity;

6. Disclose an LD₅₀ (oral, rat) range of 2–5 g/kg and an LD₅₀ (dermal, rat) value of 5.6 g/kg for zinc dialkyl dithiophosphate.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 4987

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Correct the impression that quaternary ammonium compound (No. 1) and alkylaryl sulfonate are regulated components of the controlled product;

2. Disclose that metal containers should be grounded when transferring quantities of the controlled product;

3. Disclose that an ingredient in the controlled product is incompatible with aluminum powder, potassium tert-butoxide, and 2-butanone;

4. Disclose that acute inhalation of ingredients in the controlled product has been shown to cause respiratory tract irritation and adverse lung effects;

5. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;

6. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular and kidney effects in laboratory animals;

7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 5022

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the generic chemical identity of an additional confidential hazardous ingredient in the controlled product, disclose its concentration in an acceptable manner and disclose that the real chemical identity is included in the claim for exemption;

2. Disclose an LD₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

3. Disclose that the olefin sulfide is a skin sensitizer.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 5121

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 15 minutes;

2. In relation to the first aid information shown on the MSDS for ingestion, delete the statement "Drink 1 or 2 glasses of water" and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;

3. Add oxides of nitrogen to and remove silicon oxides from the list of hazardous combustion products.

In the opinion of the Screening Officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, delete the statement "Drink 1 or 2 glasses of water" and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;

2. In relation to the first aid information shown on the label for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 15 minutes;

3. Modify the English-language portion of the label to disclose a statement similar to "Wear appropriate protective equipment. Ensure adequate ventilation."

Registry Number 5153

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add certain further substances or classes of substances to the list of incompatible materials;

2. Disclose that an ingredient in the controlled product has shown positive test results in an in vivo screening test for mutagenicity.

Registry Number 5155

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add oxides of sulfur to the list of hazardous thermal decomposition products.

Registry Number 5183

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with water for 20–30 minutes;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give a conscious casualty large quantities of water to drink;

3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.

Registry Number 5196

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 5237

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1A and D2A and amend the disclosure to state that the controlled product is in class E rather than D2B;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with lukewarm, gently flowing water for at least 20–30 minutes;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 20–30 minutes or until the chemical is removed;

4. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or pulmonary resuscitation if breathing has stopped or the heart has stopped;

5. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;

6. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular and kidney effects in laboratory animals;

7. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human cells, in vitro;

8. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and teratogenic effects in laboratory animals;

9. Disclose an LC₅₀ (4 hours, rat) value of 16 970 ppm for propan-2-ol;

10. Disclose a lower LD₅₀ (dermal, rabbit) value of 99 mg/kg for 2-butoxyethanol.

Registry Number 5258

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with water for at least 20 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "If patient is fully conscious, give two glasses of water."

Registry Numbers 5259 to 5263, inclusive

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed for at least 20–30 minutes;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "If patient is fully conscious, give two glasses of water."

Registry Number 5267

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for 20 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "If patient is fully conscious, give two glasses of water";

3. Disclose that an ingredient in the controlled product has been shown to cause skin irritation in laboratory animals;

4. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals.

Registry Number 5272

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "If patient is fully conscious, give two glasses of water";

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed.

Registry Number 5285

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Correctly characterize those products listed as being products of hazardous decomposition as being products of hazardous combustion and add oxides of sulfur to the list.

Registry Numbers 5291 and 5443

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS Registry Number and percent concentration;

2. Disclose that ingredients in the controlled product have been shown to cause dermal sensitization in laboratory animals;

3. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro;

4. In relation to the first aid information shown on the MSDS for ingestion, modify or remove the statement to give water to drink.

Registry Number 5292

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water.

Acknowledgement: Subsequent to the issuance of the decision and order on the claim for exemption, the claimant advised the Commission that sales in Canada of the relevant controlled product has ceased. Consequently, the order issued by the Screening Officer has effect only if the controlled product is again offered for sale in Canada.

Registry Number 5297

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Replace the percent concentration ranges for methacrylic acid esters (1) and (2) with acceptable WHMIS percent concentration ranges;

2. Disclose a dermal LD₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

3. Disclose an LC₅₀ (1 hour, rat) range of 1.26 mg/L to 2.83 mg/L for synthetic amorphous silica;

4. Clarify that the LD₅₀ values shown on the MSDS are relevant to the oral route of exposure;

5. Disclose the Exposure Limit Value ACGIH TLV–TWA = 0.05 mg/m³ (respirable) A2 for silicon dioxide;

6. Disclose an Exposure Limit Value for one of the confidential hazardous ingredients;

7. Disclose that an ingredient in the controlled product has been shown to cause adverse reproductive effects in male laboratory animals;

8. Disclose that an ingredient in the controlled product has been shown to cause developmental effects in laboratory animals at maternally toxic dose levels;

9. Disclose that an ingredient in the controlled product has shown positive results in an in vitro screening test for mutagenicity;

10. In relation to the first aid information shown on the MSDS for ingestion, modify or remove the statement to give water to drink;

11. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 5302

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of dimethyl succinate polymer with 4-hydroxy-2,2,6,6-tetramethyl-1-piperidineethanol in the controlled product, its CAS Registry Number 65447-77-0 and its percent concentration;

2. Disclose Exposure Limit Values for the confidential hazardous ingredient;

3. Disclose that an ingredient in the controlled product is incompatible with linseed oil or similar fatty acid compounds;

4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two to four glasses of water to drink.

Registry Numbers 5306 and 5313

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "If patient is fully conscious, give two glasses of water."

Registry Number 5315

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, modify or remove the statement to give water or milk to drink.

Registry Number 5307

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with water for at least 20 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "If patient is fully conscious, give two glasses of water."

Registry Number 5325

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of N-phenyl-p-phenylenediamine in the controlled product, its CAS Registry Number 101-54-2 and its percent concentration;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

3. Add oxides of nitrogen to the list of hazardous thermal decomposition products;

4. Add skin contact as a route of entry;

5. Disclose that an ingredient in the controlled product has been shown to cause skin irritation in laboratory animals;

6. Disclose an LD₅₀ value for the confidential hazardous ingredient in an acceptable manner.

Registry Number 5336

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A;

2. Remove the information pertaining to the LD₅₀ range values for certain of the ingredients in the controlled product;

3. Disclose an LD₅₀ (oral, rat) value of 2 080 mg/kg and an LC₅₀ (4 hours, rat, aerosol) value of <70 mg/m³ for 1,2-ethanediamine, N-(2-aminoethyl)-;

4. Disclose an LD₅₀ (oral, rat) value of 380 mg/kg for 1,6-hexanediamine;

5. Disclose an LD₅₀ (oral, rat) value of 1 280 mg/kg for phenol, 2,4,6-tris[(dimethylamino)methyl]-;

6. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20–30 minutes or until the chemical is removed;

7. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water to drink and add advice to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

Registry Number 5337

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B;

2. Disclose a lower LD₅₀ value for the confidential hazardous ingredient;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed.

Registry Numbers 5338 and 5339

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Remove the information pertaining to the LD₅₀ range values for certain of the ingredients in the controlled product;

2. Disclose an Exposure Limit Value AIHA WEEL = 5 mg/m³ with a skin notation for the confidential hazardous ingredient mercaptan;

3. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for at least 20 minutes or until the chemical is removed;

5. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water to drink;

6. Registry Number 5339:

(a) Disclose the Exposure Limit Value OSHA PEL = 80 mg/m³ divided by the value "%SiO₂" for silica, amorphous;

(b) Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse effects on the lungs of laboratory animals.

Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the Screening Officer.

Registry Numbers 5343 and 5344

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose a lower LD₅₀ (oral, female rat) value of 1 131 mg/kg for sodium metabisulfite;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water to drink.

Registry Number 5350

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with water for at least 20 minutes;

3. Disclose oxides of carbon and nitrogen as hazardous combustion products.

Registry Number 5366

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of N-phenyl-p-phenylenediamine in the controlled product, its CAS Registry Number 101-54-2 and its percent concentration;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

3. Add oxides of nitrogen to the list of hazardous thermal decomposition products;

4. Add skin contact and eye contact as routes of entry;

5. Disclose that an ingredient in the controlled product has been shown to cause skin irritation in laboratory animals;

6. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredient in an acceptable manner.

Registry Number 5371

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of fatty acids, tall oil, 2-mercaptoethyl esters in the controlled product, their CAS Registry Number 68440-24-4 and their percent concentration;

2. In relation to the first aid information shown on the MSDS for inhalation, add that medical attention should be obtained;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

4. Remove the information pertaining to the lower bound for the oral LD₅₀ value for the methyltin mercaptide sulfides in the controlled product;

5. Disclose that alkyl mercaptan has been shown to cause dermal sensitization in laboratory animals.

Registry Number 5388

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Numbers 5421 and 5422

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of carbon black in an acceptable manner;

2. Revise the MSDS to show that crystalline silica has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH);

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for 20 minutes or until the chemical is removed;

4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human cells, in vitro;

5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro;

6. Registry Number 5422: Disclose the Exposure Limit Value OSHA PEL = 20 ppm for magnesium silicate hydrate.

Registry Number 5423

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Revise the MSDS to show that crystalline silica has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH);

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for 20 minutes or until the chemical is removed.

Registry Number 5424

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional hazardous ingredient in the controlled product together with its OSHA PEL Exposure Limit Value;

2. Revise the MSDS to show that crystalline silica has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH);

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for 20 minutes or until the chemical is removed;

4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human cells, in vitro.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Numbers 5430 and 5431

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose a lower LD₅₀ (oral, rat) value of 1 945 mg/kg and an LD₅₀ (dermal, rabbit) value of 6 220 mg/kg for N-methyldiethanolamine;

2. Disclose a dermal LD₅₀ value for the confidential hazardous ingredient in an acceptable manner;

3. Disclose oxides of carbon and nitrogen as hazardous combustion products;

4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water to drink;

5. Registry Number 5430:

(a) Remove the statement that the controlled product is not irritating to the skin;

(b) In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

6. Registry Number 5431:

(a) In relation to the period of time shown on the MSDS for flushing the eyes with water should eye contact occur, delete the current reference to "fifteen minutes" and replace it with a time of "from twenty to thirty minutes";

(b) In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20–30 minutes.

Registry Number 5446

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the value of a lower bound for the oral LD₅₀ value for one of the confidential hazardous ingredients;

2. Disclose an LC₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

3. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;

4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Registry Number 5450

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

3. Disclose that grounded equipment be used when handling large quantities of the controlled product;

4. Disclose the Exposure Limit Values ACGIH TLV–TWA = 200 ppm and ACGIH TLV–STEL = 400 ppm for isopropanol;

5. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause hearing loss in laboratory animals;

6. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular and kidney effects in laboratory animals;

7. Disclose an LD₅₀ (oral, rat) value of 3 200 mg/kg, for heavy aromatic naphtha;

8. Disclose an LD₅₀ (oral, male rat) value of 4.82 g/kg for heavy catalytic reformed naphtha;

9. Disclose an LD₅₀ (oral, rat) value of 6.0 mL/kg, an LD₅₀ (dermal, rabbit) value of 16.4 mL/kg and an LC₅₀ (4 hours, rat) value of 16 970 ppm for isopropanol;

10. Disclose an LD₅₀ (oral, male rat) value of 3 523 mg/kg and an LC₅₀ (4 hours, rat) value of 6 350 ppm for xylene;

11. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro;

12. Disclose that hexane synergistically enhances the hearing loss caused by inhalation exposure to xylene in laboratory animals;

13. Disclose that inhalation of an ingredient in the controlled product has been shown to cause fetotoxicity and postnatal developmental toxicity in laboratory animals;

14. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects and developmental effects in laboratory animals;

15. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 5463

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of isopropanol in the controlled product, its CAS Registry Number 67-63-0 and its percent concentration;

2. Correct the impression that ethylbenzene and xylene are regulated components of the controlled product;

3. Disclose skin absorption as a route of entry;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;

5. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or pulmonary resuscitation if breathing has stopped or the heart has stopped;

6. Disclose an Exposure Limit Value AIHA WEEL = 0.2 ppm for one of the confidential hazardous ingredients;

7. Disclose that ingestion of an ingredient in the controlled product has been shown to cause damage to the eyes of laboratory animals;

8. Disclose LD₅₀ values for one of the confidential hazardous ingredients in an acceptable manner;

9. Disclose LD₅₀ (dermal, rabbit) values of 320 mg/kg and 99 mg/kg and an LC₅₀ (4 hours, rat) value of 450 ppm for 2-butoxyethanol;

10. Disclose that the organic sulfur compound is a dermal sensitizer in laboratory animals;

11. Disclose that ingredients in the controlled product are considered to be fetotoxins;

12. Disclose that ingredients in the controlled product have been shown to cause mutagenic effects in human cells, in vitro;

13. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

Registry Number 5471

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that acute exposure to an ingredient in the controlled product can be corrosive to the eyes and skin;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement indicating one should give large quantities of water to drink and replace it with a statement such as the following: Have casualty rinse mouth thoroughly with water. Have casualty drink 250–300 mL of water to dilute the ingested material. If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;

3. In relation to the first aid information shown on the MSDS for eye contact, disclose that flushing should continue for at least 60 minutes;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose that flushing should continue for at least 60 minutes and that medical advice should be sought immediately.

In the opinion of the Screening Officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.

1. Disclose that the controlled product can be corrosive to the eyes and skin;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement indicating one should give large quantities of water to drink and replace it with a statement such as the following: Have casualty rinse mouth thoroughly with water. Have casualty drink 250–300 mL of water to dilute the ingested material. If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;

3. In relation to the first aid information shown on the MSDS for eye contact, disclose that flushing should continue for at least 60 minutes;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose that flushing should continue for at least 60 minutes and that medical advice should be sought immediately;

5. Modify the English-language portion of the label to disclose a statement similar to "Wear appropriate protective equipment";

6. Disclose detailed information regarding the personal protective equipment to be worn when handling the controlled product.

Registry Number 5492

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 5495

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 5496

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 60 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose that flushing should continue for at least 60 minutes or until the chemical is removed;

3. Disclose the Exposure Limit Value ACGIH TLV–TWA = 0.05 mg/m³ (respirable) for silica, quartz.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 5532

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of fatty acids, tall oil, 2-mercaptoethyl esters in the controlled product, their CAS Registry Number 68440-24-4 and their percent concentration;

2. In relation to the first aid information shown on the MSDS for inhalation, add that medical attention should be obtained;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

4. Remove the information pertaining to the lower bound for the oral LD₅₀ value for the methyltin mercaptide sulfides in the controlled product;

5. Disclose that alkyl mercaptan has been shown to cause dermal sensitization in laboratory animals.

Registry Number 5545

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

Registry Number 5546

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that acute inhalation of an ingredient of the controlled product has been shown to cause adverse CNS effects in laboratory animals;

2. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the bone marrow as well as sperm effects in laboratory animals;

3. Add strong acids to the list of incompatible materials.

Registry Number 5551

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

Registry Number 5552

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of two additional confidential hazardous ingredients in the controlled product, together with their percent concentrations.

Registry Numbers 5560 to 5564, inclusive

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with gently flowing, lukewarm water for 20 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

3. Disclose that ingredients in the controlled product have been shown to cause mutagenic effects in mammalian cells, in vitro;

4. Disclose that ingredients in the controlled product have been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;

5. Registry Number 5560: Replace the percent concentration range for methyl 1,2,2,6,6-pentamethyl-4-piperidinyl sebacate with an acceptable WHMIS percent concentration range;

6. Registry Number 5562: Replace the percent concentration range for isooctyl acrylate with an acceptable WHMIS percent concentration range.

Registry Number 5570

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product is incompatible with acetyl bromide, aluminum powder, magnesium, aluminum and zinc salts, boron trichloride and cyanuric chloride;

2. Disclose that an ingredient in the controlled product has shown positive test results in an in vivo screening test for mutagenicity;

3. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause CNS effects and eye effects in laboratory animals.

Registry Number 5573

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for 20 minutes or until the chemical is removed;

2. Disclose an LD₅₀ (oral, rat) value of 3 200 mg/kg for heavy aromatic naphtha.

Registry Number 5585

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 5593

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

Registry Numbers 5598 and 5599

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Correct the impression that xylene and trimethylbenzenes are regulated components of the controlled product.

Registry Number 5621

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (oral, rat) value of 2.46 mL/kg for 2-ethylhexanol.

Registry Number 5632

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of phosphoric acid, bis(2-ethylhexyl) ester in the controlled product, its CAS Registry Number 298-07-7 and its percent concentration;

2. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20–30 minutes. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

5. In relation to the period of time shown on the MSDS for flushing the eyes with water should eye contact occur, delete the current reference to "fifteen minutes" and replace it with a time of "from twenty to thirty minutes";

6. Add oxides of nitrogen to the list of hazardous thermal decomposition products;

7. Disclose that the long-chain alkyl amine is a skin sensitizer;

8. Disclose dermal LD₅₀ values for the confidential hazardous ingredients and an LC₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

9. Disclose an LD₅₀ (oral, rat) value of 2 710 mg/kg for phosphoric acid, bis(2-ethylhexyl) ester;

10. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Registry Numbers 5633 and 5634

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (oral, rat) value of 8 400 mg/kg for naphtha (petroleum), light aromatic;

2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class B3.

Registry Number 5931

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 5942

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity.

Registry Number 5949

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product is incompatible with acrylaldehyde, aluminum and potassium tert-butoxide.

Having regard to the foregoing, and pursuant to section 17 of the Hazardous Materials Information Review Act, notice is hereby given that the Screening Officer has, for each of the above-noted claims, with the exceptions of those claims bearing Registry Numbers 4902, 5121, 5284, 5471, 5770, 5941 and 5973, directed the claimant to comply with the provisions of the Hazardous Products Act and the Controlled Products Regulations within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the Screening Officer within 40 days of expiry of the appeal period.

In the case of the claims bearing Registry Numbers 5121 and 5471, the Screening Officer has ordered the claimant to comply with the provisions of the Occupational Health and Safety Code of the province of Alberta, except that the information in respect of which the claims for exemption were made does not have to be disclosed, and to provide copies of the amended MSDSs and the amended labels to the Screening Officer, within the respective time period specified in the foregoing paragraph.

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, this notice includes certain information which, in the opinion of the Screening Officer, should have been shown on the relevant MSDS or label.

Pursuant to subsection 24(1) of the Controlled Products Regulations, amended MSDSs must be available in both official languages.

Section 20 of the Hazardous Materials Information Review Act affords the opportunity to a claimant or any affected party, within the meaning of subsection 2(2) of the Hazardous Materials Information Review Regulations, to appeal a decision or order of a Screening Officer. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered within 45 days of the publication of this notice in the Canada Gazette, Part I, to the Chief Appeals Officer at the following address: Hazardous Materials Information Review Commission, 427 Laurier Avenue W, 7th Floor, Ottawa, Ontario K1A 1M3, (613) 993-4429.

R. BOARDMAN
Chief Screening Officer

[22-1-o]

PUBLIC SERVICE EMPLOYMENT ACT

Leave of absence granted

The Public Service Commission of Canada, pursuant to subsection 33(4) of the Public Service Employment Act, hereby gives notice that it has granted a leave of absence without pay, pursuant to subsection 33(3) of the said Act, to Mr. Keith Fountain, Deputy Director (FS-02), Afghanistan Section, South and Southeast Asia Bureau, Foreign Affairs Canada, Ottawa, Ontario, to allow him to be a candidate in the next federal election in the riding of Ottawa Centre, Ontario. This leave will take effect at the close of the nomination meeting should Mr. Fountain be nominated as a candidate.

May 13, 2005

MARIA BARRADOS
President

[22-1-o]